br Appendix A Supplementary data br Ofoma

Appendix A. Supplementary data
1. Ofoma UR, Basnet S, Berger A, Kirchner HL, Girotra S, American Heart Association Get With the Guidelines – Resuscitation Investigators. Trends in survival after in-hospital cardiac arrest during nights and weekends. J Am Coll Cardiol 2018;71:402–11.
2. Chan PS, Krein SL, Tang F, et al. Resuscitation practices associated with survival after in-hospital cardiac arrest: LY 294002 nationwide survey. JAMA Cardiol 2016;1:189–97.
3. Edelson DP, Litzinger B, Arora V, et al. Improving in-hospital cardiac arrest process and outcomes with performance debriefing. Arch Intern Med 2008;168:1063–9.
continuous quality improvement: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2015;132:S397–413.
6. Neumar RW. Doubling cardiac arrest survival by 2020: achieving the American Heart Association impact goal. Circulation 2016;134:2037–9. 7. Monsieurs KG, Nolan JP, Bossaert LL, et al. European Resuscitation Council guidelines for resuscitation 2015: section 1. Executive summary. Resuscitation 2015;95:1–80.
9. Wiczer TE, Levine LB, Brumbaugh J, et al. Cumulative incidence, risk factors, and management of atrial fibrillation in patients receiving ibrutinib. Blood Adv 2017;1:1739–48.
10. Bruckel JT, Wong SL, Chan PS, Bradley SM, Nallamothu BK. Patterns of resuscitation care and survival after in-hospital cardiac arrest in patients with advanced cancer. J Oncol Pract 2017;13:e821–30.
11. Nolan JP, Morley PT, Vanden Hoek TL, et al. Therapeutic hypothermia after cardiac arrest: an advisory statement by the advanced life support task force of the International Liaison Committee on Resuscitation. Circulation 2003;108:118–21.
13. De Bruin ML, van Hemel NM, Leufkens HGM, Hoes AW. Hospital discharge diagnoses of ventricular arrhythmias and cardiac arrest were useful for epidemiologic research. J Clin Epidemiol 2005;58:1325–9.
14. Sean H, Leonard CE, Freeman CP, et al. Validation of diagnostic codes for outpatient-originating sudden cardiac death and ventricular arrhythmia in medicaid and medicare claims data. Pharmacoepidemiol Drug Saf 2010;19:555–62. 
15. Tamariz L, Harkins T, Nair V. A systematic review of validated methods for identifying ventricular arrhythmias using administrative and claims data. Pharmacoepidemiol Drug Saf 2012;21:148–53.
16. Overview of disease severity measures disseminated with the nationwide inpatient sample (NIS) and kids’ inpatient database (KID). Rockville, MD: AHRQ; 2005.
17. Moore BJ, White S, Washington R, Coenen N, Elixhauser A. Identifying increased risk of readmission and in-hospital mortality using hospital administrative data: the AHRQ Elixhauser comorbidity index. Med Care 2017;55:698–705.
21. Parsons LS. Performing a Syntenic genetic loci 1: N case-control match on propensity score. Proceedings of the 29th annual SAS users group international conference 2004 p. 165-29.
22. Age-adjusted SEER incidence and U.S. death rates and 5-year relative survival (percent) by primary cancer site, sex and time period. SEER cancer statistics review (CSR) 1975–2014. National Cancer Institute; 2014.
24. Secemsky EA, Rosenfield K, Kennedy KF, Jaff M, Yeh RW. High burden of 30-day readmissions after acute venous thromboembolism in the United States. J Am Heart Assoc 20187:.
25. Schwarze ML, Nabozny MJ, Steffens NM. Cardiopulmonary resuscitation and benefit to patients with metastatic cancer—reply. JAMA Intern Med 2016;176:142–3.
28. Iliescu C, Grines CL, Herrmann J, et al. SCAI expert consensus statement: evaluation, management, and special considerations of cardio-oncology patients in the cardiac catheterization laboratory (endorsed by the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencionista). Catheter Cardiovasc Interv 2016;87:895–9.